Rhumbline Advisers Has $160.58 Million Stock Holdings in The Cigna Group (NYSE:CI)

Rhumbline Advisers lessened its holdings in The Cigna Group (NYSE:CI) by 1.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 581,500 shares of the health services provider’s stock after selling 7,386 shares during the period. Rhumbline Advisers owned about 0.21% of The Cigna Group worth $160,575,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. Prospera Private Wealth LLC acquired a new stake in shares of The Cigna Group in the third quarter worth about $37,000. Collier Financial acquired a new position in shares of The Cigna Group during the 4th quarter worth about $32,000. ORG Wealth Partners LLC acquired a new position in shares of The Cigna Group during the 4th quarter worth about $34,000. Harbor Capital Advisors Inc. acquired a new position in shares of The Cigna Group during the 3rd quarter worth about $45,000. Finally, Compagnie Lombard Odier SCmA acquired a new position in shares of The Cigna Group during the 4th quarter worth about $37,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Stock Down 2.6 %

NYSE CI opened at $292.12 on Friday. The firm has a market cap of $81.25 billion, a PE ratio of 23.87, a price-to-earnings-growth ratio of 0.94 and a beta of 0.54. The Cigna Group has a one year low of $262.03 and a one year high of $370.83. The stock’s 50 day simple moving average is $286.97 and its 200 day simple moving average is $321.46. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72.

The Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the prior year, the business earned $6.79 EPS. As a group, sell-side analysts forecast that The Cigna Group will post 29.8 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be issued a dividend of $1.51 per share. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 annualized dividend and a yield of 2.07%. The Cigna Group’s dividend payout ratio is currently 49.35%.

Analyst Ratings Changes

Several research firms recently weighed in on CI. Morgan Stanley cut their price objective on The Cigna Group from $403.00 to $379.00 and set an “overweight” rating for the company in a research report on Friday, January 31st. UBS Group cut their price target on The Cigna Group from $410.00 to $390.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Deutsche Bank Aktiengesellschaft cut their price target on The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a report on Monday, November 4th. Wells Fargo & Company cut their price target on The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating for the company in a report on Tuesday, February 4th. Finally, Sanford C. Bernstein cut The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price target for the company. in a report on Thursday, February 6th. Three equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, The Cigna Group currently has an average rating of “Moderate Buy” and an average price target of $373.69.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.